These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Rollema H; Coe JW; Chambers LK; Hurst RS; Stahl SM; Williams KE Trends Pharmacol Sci; 2007 Jul; 28(7):316-25. PubMed ID: 17573127 [TBL] [Abstract][Full Text] [Related]
10. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Stapleton JA; Watson L; Spirling LI; Smith R; Milbrandt A; Ratcliffe M; Sutherland G Addiction; 2008 Jan; 103(1):146-54. PubMed ID: 18028247 [TBL] [Abstract][Full Text] [Related]
11. [New drugs; varenicline]. van Bronswijk H; Dubois EA; Zitman FG; Cohen AF Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2503-4. PubMed ID: 18062594 [TBL] [Abstract][Full Text] [Related]
12. Varenicline reduced smoking behaviour in a mentally ill person. Ochoa EL J Psychopharmacol; 2009 May; 23(3):340-1. PubMed ID: 18562426 [No Abstract] [Full Text] [Related]
13. Reduced affective symptoms during tobacco dependence treatment with varenicline. Grosshans M; Mutschler J; Hermann D; Mann K; Diehl A Addiction; 2009 May; 104(5):859-61. PubMed ID: 19413797 [TBL] [Abstract][Full Text] [Related]
14. [New tobacco dependence drug: Varenicline, partial agonist of alpha4beta2 acetylcholine-nicotine receptors]. Králíková E Cas Lek Cesk; 2006; 145(11):832-4. PubMed ID: 17168413 [TBL] [Abstract][Full Text] [Related]
15. The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician. Crane R Prim Care; 2007 Mar; 34(1):117-35. PubMed ID: 17481990 [No Abstract] [Full Text] [Related]
16. Varenicline (Chantix) for tobacco dependence. Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):66-8. PubMed ID: 16977281 [No Abstract] [Full Text] [Related]
17. Nicotine receptor partial agonists for smoking cessation. Lin KW Am Fam Physician; 2011 Oct; 84(7):769. PubMed ID: 22010613 [No Abstract] [Full Text] [Related]
18. Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines. Reus VI; Smith BJ Int J Clin Pract; 2008 Nov; 62(11):1753-68. PubMed ID: 18795968 [TBL] [Abstract][Full Text] [Related]
19. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of varenicline for smoking cessation. Hays JT; Ebbert JO; Sood A Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]